Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PTC”

567 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 567 results

Not applicableUnknownNCT04664413
What this trial is testing

Percentage of BRAFV600E Alleles and Outcome in Thyroid Carcinoma

Who this might be right for
Papillary Thyroid Cancer
University of Salerno 300
Not applicableUnknownNCT05446441
What this trial is testing

Endoscopic Thyroidectomy Versus Open Thyroidectomy for Papillary Thyroid Carcinoma

Who this might be right for
Thyroid Cancer
Zhejiang Provincial People's Hospital 634
Not applicableLooking for participantsNCT06565481
What this trial is testing

Measurement Properties in People with Hemophilia

Who this might be right for
Hemophilia aHemophilia BMusculoskeletal Complication+1 more
University of Zurich 50
Early research (Phase 1)Study completedNCT01228669
What this trial is testing

Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B+1 more
Novo Nordisk A/S 52
Not applicableStudy completedNCT01154231
What this trial is testing

BeneFIX Drug Use Results Survey [All-Case Surveillance]

Who this might be right for
Hemophilia B
Pfizer 314
Large-scale testing (Phase 3)Ended earlyNCT05568888
What this trial is testing

Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study )

Who this might be right for
Traumatic Injury
CSL Behring 1,366
Testing effectiveness (Phase 2)Study completedNCT00591786
What this trial is testing

A Bridging Trial Comparing Sugammadex (Org 25969) at 1-2 Post-Tetanic Count (PTC) in Japanese Participants. Part A (P05957)

Who this might be right for
Anesthesia, General
Merck Sharp & Dohme LLC 100
Testing effectiveness (Phase 2)Study completedNCT03407651
What this trial is testing

Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
Catalyst Biosciences 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Not applicableStudy completedNCT00927992
What this trial is testing

Study Evaluating Liver Transplantation in Haemophilia Patients in Spain

Who this might be right for
HemophiliaHemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 11
Large-scale testing (Phase 3)Looking for participantsNCT04867837
What this trial is testing

Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor

Who this might be right for
Acute Major Bleeding
Octapharma 260
Not applicableStudy completedNCT06439745
What this trial is testing

More Than 50% of Unifocal cN0 T1b/Small T2 Papillary Thyroid Carcinoma May Require Completion Thyroidectomy if Nodal Status is Evaluated

Who this might be right for
Papillary Thyroid CancerPapillary CarcinomaThyroid Cancer+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 314
Not applicableUnknownNCT01565486
What this trial is testing

Safety and Efficacy Study of Ultrasonic Coagulation Device and Bipolar Energy Sealing System

Who this might be right for
Thyroid Cancer
Seoul St. Mary's Hospital 304
Early research (Phase 1)Study completedNCT01921855
What this trial is testing

Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Bayer 16
Testing effectiveness (Phase 2)Study completedNCT00134043
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer

Who this might be right for
Insular Thyroid CancerRecurrent Thyroid CancerStage II Follicular Thyroid Cancer+4 more
National Cancer Institute (NCI) 19
Early research (Phase 1)Ended earlyNCT03469011
What this trial is testing

Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.

Who this might be right for
Papillary Thyroid Cancer
AHS Cancer Control Alberta 14
Not applicableUnknownNCT02814032
What this trial is testing

Proteomics of Papillary Thyroid Carcinoma

Who this might be right for
Papillary Thyroid Carcinoma
The Affiliated Hospital of Inner Mongolia Medical University 32
Not applicableStudy completedNCT01503567
What this trial is testing

Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia A With Inhibitors+2 more
Novo Nordisk A/S 282
Not applicableNot Yet RecruitingNCT07545837
What this trial is testing

Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors

Who this might be right for
Thyroid Gland Follicular CarcinomaThyroid Gland Papillary Carcinoma
Mayo Clinic 20
Large-scale testing (Phase 3)Study completedNCT01333111
What this trial is testing

Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B Patients

Who this might be right for
Congenital Bleeding DisorderHaemophilia B
Novo Nordisk A/S 74
Load More Results